These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16463710)

  • 21. Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD.
    Jones PW; Mahler DA; Gale R; Owen R; Kramer B
    Respir Med; 2011 Jun; 105(6):892-9. PubMed ID: 21397482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Long-acting beta-2-adrenergic agonists in bronchospasm therapy].
    Płusa T
    Pol Merkur Lekarski; 1999 May; 6(35):227-31. PubMed ID: 10437387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Something old, something new, something borrowed. COPD treatment today.
    Goldman CA; Robinson EM; Goldman MD
    Adv Nurse Pract; 2006 Feb; 14(2):49-51, 61. PubMed ID: 16471309
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of delayed-action beta-2 mimetics in the management of chronic obstructive bronchial diseases--for].
    Muir JF; Cuvelier A
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S75-6. PubMed ID: 10088257
    [No Abstract]   [Full Text] [Related]  

  • 26. Gas exchange response to short-acting beta2-agonists in chronic obstructive pulmonary disease severe exacerbations.
    Polverino E; Gómez FP; Manrique H; Soler N; Roca J; Barberà JA; Rodríguez-Roisin R
    Am J Respir Crit Care Med; 2007 Aug; 176(4):350-5. PubMed ID: 17431221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultra-LAMA, ultra-LABA, ultra-inhaled steroids? The future has landed.
    Domingo C
    Arch Bronconeumol; 2013 Apr; 49(4):131-4. PubMed ID: 23415574
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diversities in the treatment of patients with chronic obstructive lung disease].
    Kozielski J
    Pol Merkur Lekarski; 2003 Jun; 14(84):666-7. PubMed ID: 14524298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-adrenoceptor responses of the airways: for better or worse?
    Broadley KJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comments of the German Airway League and the German Respiratory Society to the US Food and Drug Administration (FDA)'s announcement from February 18th 2010 on the use of long acting beta-2 agonists in treatment of asthma].
    Kardos P; Berdel D; Buhl R; Criée CP; Freihorst J; Gillissen A; Karg O; Pfeifer M; Magnussen H; Rabe KF; Teschler H; Vogelmeier C; Welte T; Wettengel R; Worth H
    Pneumologie; 2010 Jun; 64(6):333-5. PubMed ID: 20533125
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence of tachyphylaxis associated with salmeterol treatment of chronic obstructive pulmonary disease patients.
    Tsagaraki V; Amfilochiou A; Markantonis SL
    Int J Clin Pract; 2006 Apr; 60(4):415-21. PubMed ID: 16620353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.
    Beeh KM; Beier J
    Adv Ther; 2010 Mar; 27(3):150-9. PubMed ID: 20411368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of bronchodilators: searching for objective criteria].
    Aguilaniu B
    Rev Pneumol Clin; 2003 Apr; 59(2 Pt 2):S11-5. PubMed ID: 12966780
    [No Abstract]   [Full Text] [Related]  

  • 34. An analysis of the utilisation and expenditure of medicines dispensed for the management of severe asthma.
    McGowan B; Bennett K; Barry M; Owens M; O'Connor M
    Ir Med J; 2009 Mar; 102(3):73-6. PubMed ID: 19489193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhalation devices for long-acting beta2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD.
    Molimard M; Till D; Stenglein S; Singh D; Krummen M
    Curr Med Res Opin; 2007 Oct; 23(10):2405-13. PubMed ID: 20350055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choice of bronchodilator therapy for patients with COPD.
    Wedzicha JA
    N Engl J Med; 2011 Mar; 364(12):1167-8. PubMed ID: 21428773
    [No Abstract]   [Full Text] [Related]  

  • 37. Dual dopamine D2 receptor and beta2-adrenoceptor agonists for the treatment of chronic obstructive pulmonary disease: the pre-clinical rationale.
    Dougall IG; Young A; Ince F; Jackson DM
    Respir Med; 2003 Jan; 97 Suppl A():S3-7. PubMed ID: 12564606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Will SUMMIT reach the peak in COPD?
    Suissa S
    Thorax; 2014 May; 69(5):405-7. PubMed ID: 24563193
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of β2-adrenergic receptors in chronic obstructive pulmonary disease.
    Yang A; Yu G; Wu Y; Wang H
    Life Sci; 2021 Jan; 265():118864. PubMed ID: 33301808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long acting β
    Yamanashi K; Marumo S; Sumitomo R; Shoji T; Fukui M; Katayama T; Huang CL
    J Cardiothorac Surg; 2017 May; 12(1):35. PubMed ID: 28526052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.